WC Bioscience Accelerator Participants
![Cyril Eleftheriou HS Cyril Eleftheriou HS](https://wcbaccelerator.com/wp-content/uploads/2021/05/Cyril-Eleftheriou-HS-300x300.jpg)
Co-Nexi Vision
Cyril Eleftheriou
Cyril has an artificial dopaminergic neuron for treating light-adaptation deficits in the retinas of patients with dystrophic retinal conditions, including night-blindness.
Co-Nexi Vision
Cyril has an artificial dopaminergic neuron for treating light-adaptation deficits in the retinas of patients with dystrophic retinal conditions, including night-blindness.